DGAP-News
Geratherm Medical AG: New SRA Technology detects atrial fibrillation at an early stage and prevents strokes - Seite 2
The free access publication of the study with the title "Improved detection
of paroxysmal atrial fibrillation utilizing a software-assisted
electrocardiogram approach" is available at:
http://apoplexmedical.com/index.php/en/news/studie
About apoplex medical technologies
apoplex medical technologies GmbH was founded in 2004 in Pirmasens, in the
west of the Rhineland-Palatinate, and, within the field of medical
technology, specializes in new and innovative technological products for
the prevention of strokes throughout the world. The subsidiary of Geratherm
Medical AG focuses on easily applicable and efficient methods of patient
screening using medical-technical applications to prevent strokes and
vascular dementia. The SRA (Stroke Risk Analysis) procedure is the first
practicable screening method for paroxysmal atrial fibrillation. It is
available in versions for use in medical practices and stroke units.
apoplex medical technologies is supported by an extensive academic and
clinical network, which professionally supplements its own core competences
in the fields of mathematics, physics and medicine. Further information is
available at www.apoplexmedical.com.
Further information
apoplex medical technologies GmbH
Albert Hirtz
Delaware Avenue 1 - 3
D-66953 Pirmasens
fon: +49/(0)6331/698998-0
fax: +49/(0)6331/698998-19
http://www.apoplexmedical.com
a.hirtz@apoplexmedical.com
End of Corporate News
---------------------------------------------------------------------
03.03.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
98716 Geschwenda
Germany
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: info@geratherm.com
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
255329 03.03.2014
apoplex medical technologies GmbH
Albert Hirtz
Delaware Avenue 1 - 3
D-66953 Pirmasens
fon: +49/(0)6331/698998-0
fax: +49/(0)6331/698998-19
http://www.apoplexmedical.com
a.hirtz@apoplexmedical.com
End of Corporate News
---------------------------------------------------------------------
03.03.2014 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: Geratherm Medical AG
Fahrenheitstraße 1
98716 Geschwenda
Germany
Phone: +49 (0)36205 98-0
Fax: +49 (0)36205 98-1 15
E-mail: info@geratherm.com
Internet: www.geratherm.com
ISIN: DE0005495626
WKN: 549562
Listed: Regulierter Markt in Frankfurt (Prime Standard);
Freiverkehr in Berlin, Düsseldorf, Hamburg, München,
Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
255329 03.03.2014
Diskutieren Sie über die enthaltenen Werte
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte